Icona eMediNexus

1.26 by IJCP Group


May 8, 2022

Informazioni su eMediNexus

Medico Premier app in rete con le riviste, i casi e aggiornamenti conferenza in diretta

Doctors are some of the busiest professionals in India today. As professionals, they face widely different educational and vocational trajectories relative to others. The enormous doctor to population shortfall in India means that doctors in India see on average 10 times the number of patients in comparison to their Western counterparts.

With the rapid pace of how medicine is evolving, it is imperative for doctors to keep updated with the latest news, technologies, procedures, drugs and information. Traditionally, doctors have relied on the pharmaceutical industry to update them through detailing, publications, live CME and conferences.

eMedinexus is a robust platform that addresses major doctor needs. Doctors are updated daily with targeted content in the form of news, cases, questions, conference updates, CME's and journals and can collaborate, discuss and post the same as well.

It also a networking platform where doctors can connect with each other, message and collaborate privately, connect with people they went to medical school/university with or with people they worked with.

Novità nell'ultima versione 1.26

Last updated on May 8, 2022

Bug fixes and speed optimizations

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento eMediNexus 1.26

Caricata da

최서원

È necessario Android

Android 5.0+

Available on

Ottieni eMediNexus su Google Play

Mostra Altro

eMediNexus Screenshot

Commento Loading...
Lingua
Ricerca...
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.